Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Psychiatry Clinical Research
Psychiatry Clinical Research


Want to learn more about our psychiatry clinical research expertise? Simply fill out this form and we will contact you.


Learn More


Lending Our Support

Alliance for Regnerative Medicine

Medpace is an active member of the Alliance for Regenerative Medicine, a Washington, DC-based non-profit organization whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies—funding, regulatory, reimbursement and others—to facilitate advances in the field.

Psychiatry CRO for Drug and Device Clinical Research

Developing effective treatments for psychiatric disorders such as depression, bipolar disorder, anxiety disorders, and schizophrenia requires unique expertise and capabilities. To streamline your clinical development, Medpace offers medical and regulatory experts, therapeutic experience, and the disciplined processes, site relationships, and technologies required to execute even the most difficult studies.

Psychiatric Studies

Our medical and operational teams have conducted Phase I-IV psychiatry trials around the world. Our staff is experienced in the following areas:
  • Addictive Disorders
  • Anxiety Disorders
  • Attention-Deficit/Hyperactivity Disorder
  • Bipolar Disorder
  • Cognition Disorders
  • Depression
  • Developmental Disorders
  • Eating Disorders
  • Schizophrenia
  • Sleeping Disorders

The Medpace Difference for Psychiatry Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our psychiatric clients benefit from:
  • Full-time, in-house psychiatrist with 17+ years in the pharmaceutical industry designing and managing trials in psychiatry and neurology
  • Skilled, proactive operational staff experienced with the unique challenges of psychiatric studies. Nearly 100 CRAs and CTMs are experienced in psychiatric research
  • In-depth knowledge of screening tools and rating scales and will provide oversight for rater services including subjective assessments, inter-rater reliability, and scale validation
  • Broad experience conducting Phase I-IV clinical trials spanning adult and pediatric populations
  • Long-term relationships with successful, experienced sites, networks, and key opinion leaders (KOLs)
  • Extensive early phase and transitional development expertise supported by Medpace’s Phase I Clinical Pharmacology Unit
  • Integrated imaging and central laboratory services, ensuring seamless logistics, review and testing
  • With a dedicated medical device division, Medpace is uniquely suited to support drug, device, diagnostics, and combination products